Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,145 public trials 553 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

The Safety and Effectiveness of 935U83 in HIV-Infected Patients

NCT00002338

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • ViRx Inc San Francisco, California, United States
  • Georgetown Univ Med Ctr Washington D.C., District of Columbia, United States
  • Goodgame Med Group Maitland, Florida, United States
  • Indiana Univ Hosp Indianapolis, Indiana, United States
View Trial Details
Completed

A Study of CI-1012 in HIV-Infected Patients

NCT00002196

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • ViRx Inc Palm Springs, California, United States
  • ViRx Inc San Francisco, California, United States
  • Central Florida Research Initiative Maitland, Florida, United States
  • Natl Institutes of Health Bethesda, Maryland, United States
View Trial Details
Completed

A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS

NCT00002294

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +26 more
Locations
  • Dr Robert Larsen Los Angeles, California, United States
  • UCI Med Ctr Orange, California, United States
  • UCSD San Diego, California, United States
  • Dr Paul Rothman Sherman Oaks, California, United States
View Trial Details
Completed

A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes

NCT00002355

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +24 more
Locations
  • Retina - Vitreous Associates Med Group Los Angeles, California, United States
  • Community Eye Med Group Pasadena, California, United States
  • Santa Clara Valley Med Ctr San Jose, California, United States
  • Univ of Colorado Health Sciences Ctr Denver, Colorado, United States
View all 13 locations
View Trial Details
Completed

A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

NCT00002268

Conditions
AIDS-Related Opportunistic Infections, Blood-Borne Infections, Communicable Diseases, +16 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Univ TX Galveston Med Branch Galveston, Texas, United States
View Trial Details

Related conditions